Background
Previous studies have provided substantial evidence on the association of Aggregatibacter actinomycetemcomitans (Aa), and its highly leukotoxic JP2 genotype, with localized aggressive periodontitis (LAP). The present study aims to evaluate the presence of JP2 in LAP individuals following periodontal treatment.
Methods
Sixty African American LAP patients between ages 5 and 25 years were examined. At baseline, pocket depth (PD), clinical attachment level (CAL), bleeding on probing (BoP) and plaque index were measured and subgingival plaque was collected from both LAP diseased sites and healthy sites for each participant. Patients received whole-mouth ultrasonic debridement, scaling and root planning and a 7-day prescription of amoxicillin and metronidazole. Participants were re-evaluated, re-sampled and received regular maintenance therapy at 3, 6 and 12-months post-treatment. PCR technique was used detect presence of the JP2 genotype before and after treatment.
Results
At baseline, the JP2 sequence was identified in 75% of LAP diseased sites and in 56.67% of healthy sites. At 3, 6 and 12-months post-treatment, patient compliance was 40, 31 and 31, respectively, and JP2 detection decreased to 17.5%, 6.45% and 3.23% respectively, in diseased sites (P<0.001) and to 2.5%, 3.23% and 0% respectively, in healthy sites (P<0.001). Clinical parameters of disease were also significantly reduced after therapy (p<0001). Additionally, significant correlations were observed between JP2 presence and mean PD (p < 0.002) and CAL (p < 0.001), post-therapy.
Conclusion
Periodontal therapy was successful in reducing clinical parameters of LAP and the subgingival presence of JP2 in diseased and healthy sites.